{
    "nctId": "NCT03382106",
    "officialTitle": "Smoking Cessation and Functional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated Emphysema",
    "inclusionCriteria": "(Smokers):\n\n* Between the age of 21 to 65 at baseline\n* Be willing to participate in a smoking cessation program\n* Be willing to attend all clinic visits\n* Must be currently smoking at least \u00bd pack/day at baseline (confirmed with cotinine level and CO Smokerlyzer)\n* \\>5 pack-year history of smoking\n* Global Initiative for Chronic Obstructive Lung Disease (GOLD) 0: FEV1\u22650.80 and FEV1/FVC\\>0.70 Forced Expiratory Volume in 1 second (FEV1), Forced Vital Capacity (FVC)\n* GOLD 1: FEV1\u22650.80 and FEV1/FVC \\< 0.70\n* GOLD 2: 0.50\u2264FEV1\\<0.80 and FEV1/FVC \\< 0.70\n* Be willing to abstain from using any nicotine patches, e-cigarettes, or marijuana for the duration of the study.\n\nInclusion Criteria (Non-smokers):\n\n* Between the age of 21 to 65 at baseline\n* Be willing to attend all clinic visits\n* Have never smoked (confirmed with cotinine level and CO smokerlyzer)\n* GOLD 0: FEV1\u22650.80 and FEV1/FVC\\>0.70\n* Must have minimum age of 21 Years\n* Must have maximum age of 65 Years",
    "exclusionCriteria": "(Smokers and Non-smokers):\n\n* Women only: Cannot be pregnant or nursing at baseline or plan to become pregnant during the course of the study\n* Body Mass Index (BMI) \\> 35\n* Allergies to shell fish, seafood, eggs or iodine\n* Heart disease, kidney disease or diabetes\n* Diagnosis of asthma\n* Any metal in or on the body (that cannot be removed) between the nose and the abdomen\n* Any major organ system disease (by judgment of the study medical team)\n* A glomerular filtration rate of 60 cc per minute or less.\n* Nitroglycerin usage or nitrates and use of phosphodiesterase 5 (PDE5) inhibitors\n* Prior history of hypersensitivity to sildenafil\n* Currently prescribed a phosphodiesterase (PDE) inhibitors medication (ex: Viagra, Cialis, etc)\n* Known Pulmonary Hypertension\n* Has used e-cigarettes and marijuana \\<1 years\n* Use of ACE Inhibitors, Calcium Channel Blockers, Angiotensin II Receptor Blockers for control of blood pressure or any combination of these three types of medications."
}